نمایش پرونده ساده آیتم

dc.contributor.authorJafari-Aghdam, N
dc.contributor.authorAdibkia, K
dc.contributor.authorPayab, S
dc.contributor.authorBarzegar-Jalali, M
dc.contributor.authorParvizpur, A
dc.contributor.authorMohammadi, G
dc.contributor.authorSabzevari, A
dc.date.accessioned2018-08-26T09:01:31Z
dc.date.available2018-08-26T09:01:31Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/55011
dc.description.abstractThe aim of the present study was to formulate methylprednisolone acetate-Eudragit® RS100 nanofibers and nanobeads by the electrospinning method. The physicochemical characteristics of the prepared electrospuns were assessed as well. The particle size and morphology were evaluated using scanning electron microscopy. The crystallinity of the drug in the nanofibers and nanobeads obtained was also studied by X-ray crystallography and differential scanning calorimetry (DSC) thermograms. In addition, FT-IR spectroscopy was applied to investigate any possible chemical interaction between the drug and carrier during the preparation process. The drug release kinetics were considered, to predict the release mechanism. Increasing the concentration of the injected solution resulted in the production of more nanofibers and less nanobeads, with the particle size ranging from 100 to 500 nm. The drug crystallinity was decreased during the electrospinning process; however, no interaction between drug and polymer was observed. The electrospuns showed faster drug release pattern compared to the pure drug. The release data were best fitted to the Weibull model, in which the corresponding shape factor values of the model were less than 0.75 indicating the diffusion mechanism of drug release. In conclusion, electrospinning could be considered as a simple and cost effective method for fabricating the drug: polymer nanofibers and nanobeads. Copyright é 2014 Informa Healthcare USA, Inc.
dc.language.isoEnglish
dc.relation.ispartofArtificial Cells, Nanomedicine and Biotechnology
dc.subjectCost effectiveness
dc.subjectCrystallography
dc.subjectDifferential scanning calorimetry
dc.subjectDrug interactions
dc.subjectElectrospinning
dc.subjectNanofibers
dc.subjectNanostructured materials
dc.subjectParticle size
dc.subjectScanning electron microscopy
dc.subjectSpinning (fibers)
dc.subjectElectrospinning method
dc.subjectElectrospinning process
dc.subjectEudragit
dc.subjectMethylprednisolone acetate
dc.subjectNanobeads
dc.subjectParticle size and morphologies
dc.subjectPhysico-chemical characterization
dc.subjectPhysicochemical characteristics
dc.subjectX ray crystallography
dc.subjecteudragit rs
dc.subjectmethylprednisolone acetate
dc.subjectdrug carrier
dc.subjectmethylmethacrylate-methacrylic acid copolymer
dc.subjectmethylprednisolone
dc.subjectmethylprednisolone acetate
dc.subjectnanofiber
dc.subjectpolymethacrylic acid derivative
dc.subjectArticle
dc.subjectchemical interaction
dc.subjectdifferential scanning calorimetry
dc.subjectdrug delivery system
dc.subjectdrug release
dc.subjectelectrospinning
dc.subjecthuman
dc.subjectparticle size
dc.subjectphysical chemistry
dc.subjectscanning electron microscopy
dc.subjectsurface tension
dc.subjectX ray crystallography
dc.subjectanalogs and derivatives
dc.subjectchemical phenomena
dc.subjectchemistry
dc.subjectelectricity
dc.subjectkinetics
dc.subjectnanotechnology
dc.subjectprocedures
dc.subjectChemical Phenomena
dc.subjectDrug Carriers
dc.subjectDrug Liberation
dc.subjectElectricity
dc.subjectKinetics
dc.subjectMethylprednisolone
dc.subjectNanofibers
dc.subjectNanotechnology
dc.subjectPolymethacrylic Acids
dc.titleMethylprednisolone acetate-Eudragit® RS100 electrospuns: Preparation and physicochemical characterization
dc.typeArticle
dc.citation.volume44
dc.citation.issue2
dc.citation.spage497
dc.citation.epage503
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.3109/21691401.2014.965309


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم